HistoSonics, Inc.

Feb 02, 2021

HistoSonics Announces First Patient Treated in US Clinical Study of Novel Sonic Beam Therapy for Liver Tumors

Jan 11, 2021

HistoSonics Receives Approval To Begin European #HOPE4LIVER Clinical Study

Oct 05, 2020

HistoSonics Announces Approval of its #HOPE4LIVER US Clinical Study

Sep 09, 2020

HistoSonics Appoints Dr. Joe Amaral to Position of Vice President of Medical Affairs

Jun 08, 2020

HistoSonics Announces $40 Million Financing

Jan 13, 2020

HistoSonics Wins Top Honors in The Observer's List of Top Healthcare Start-ups Heading into the JP Morgan Healthcare Conference

Jan 06, 2020

HistoSonics Robotic Sonic Beam Therapy Platform Wins 2019 Frost & Sullivan Innovation Award

Jun 11, 2019

HistoSonics, Non-Invasive Robotics Pioneer, Releases Promising Data at Society of Interventional Oncology (SIO)

Apr 08, 2019

HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing

Jan 07, 2019

HistoSonics Selected as One of the Hottest Startups at the 2019 J.P. Morgan Healthcare Investment Conference

Sep 19, 2017

HistoSonics Expands Leadership Team As It Accelerates Growth

Jun 07, 2017

HistoSonics Technology's Exciting Preclinical Results to be Presented at the World Conference on Interventional Oncology (WCIO) 2017